Neil Chatterji
Stock Analyst at B. Riley Securities
(1.57)
# 3,494
Out of 5,124 analysts
19
Total ratings
29.41%
Success rate
2.48%
Average return
Main Sectors:
Stocks Rated by Neil Chatterji
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLPT ClearPoint Neuro | Maintains: Buy | $20 → $28 | $15.27 | +83.37% | 4 | Apr 25, 2025 | |
| OPRX OptimizeRx | Maintains: Buy | $17 → $13 | $13.32 | -2.40% | 3 | Dec 24, 2024 | |
| ESTA Establishment Labs Holdings | Maintains: Buy | $95 → $50 | $69.32 | -27.87% | 2 | Nov 9, 2023 | |
| ARAY Accuray | Reiterates: Buy | $7.5 | $0.89 | +743.36% | 1 | Oct 4, 2023 | |
| ZUMZ Zumiez | Maintains: Neutral | $15 → $18 | $26.41 | -31.84% | 2 | Sep 8, 2023 | |
| KRMD KORU Medical Systems | Initiates: Buy | $4.5 | $5.58 | -19.35% | 1 | Sep 7, 2023 | |
| HYPR Hyperfine | Maintains: Buy | $2.5 → $3.5 | $1.02 | +243.14% | 3 | Aug 15, 2023 | |
| STXS Stereotaxis | Maintains: Buy | $6 → $5.5 | $2.55 | +115.69% | 2 | Mar 6, 2023 | |
| BFLY Butterfly Network | Initiates: Buy | $9.5 | $4.06 | +133.99% | 1 | Oct 4, 2022 |
ClearPoint Neuro
Apr 25, 2025
Maintains: Buy
Price Target: $20 → $28
Current: $15.27
Upside: +83.37%
OptimizeRx
Dec 24, 2024
Maintains: Buy
Price Target: $17 → $13
Current: $13.32
Upside: -2.40%
Establishment Labs Holdings
Nov 9, 2023
Maintains: Buy
Price Target: $95 → $50
Current: $69.32
Upside: -27.87%
Accuray
Oct 4, 2023
Reiterates: Buy
Price Target: $7.5
Current: $0.89
Upside: +743.36%
Zumiez
Sep 8, 2023
Maintains: Neutral
Price Target: $15 → $18
Current: $26.41
Upside: -31.84%
KORU Medical Systems
Sep 7, 2023
Initiates: Buy
Price Target: $4.5
Current: $5.58
Upside: -19.35%
Hyperfine
Aug 15, 2023
Maintains: Buy
Price Target: $2.5 → $3.5
Current: $1.02
Upside: +243.14%
Stereotaxis
Mar 6, 2023
Maintains: Buy
Price Target: $6 → $5.5
Current: $2.55
Upside: +115.69%
Butterfly Network
Oct 4, 2022
Initiates: Buy
Price Target: $9.5
Current: $4.06
Upside: +133.99%